nodes	percent_of_prediction	percent_of_DWPC	metapath
Metolazone—Quinethazone—SLC12A2—prostate cancer	0.00928	0.903	CrCbGaD
Metolazone—CA7—renal system—prostate cancer	0.00469	0.126	CbGeAlD
Metolazone—SLC12A3—renal system—prostate cancer	0.00459	0.124	CbGeAlD
Metolazone—CA5B—prostate gland—prostate cancer	0.00401	0.108	CbGeAlD
Metolazone—CA12—renal system—prostate cancer	0.00304	0.0821	CbGeAlD
Metolazone—CA4—prostate gland—prostate cancer	0.00277	0.0746	CbGeAlD
Metolazone—CA5B—urethra—prostate cancer	0.00268	0.0723	CbGeAlD
Metolazone—CA9—testis—prostate cancer	0.00266	0.0717	CbGeAlD
Metolazone—CA4—seminal vesicle—prostate cancer	0.00234	0.0631	CbGeAlD
Metolazone—CA4—renal system—prostate cancer	0.00188	0.0508	CbGeAlD
Metolazone—CA4—urethra—prostate cancer	0.00185	0.0499	CbGeAlD
Metolazone—CA5B—testis—prostate cancer	0.00177	0.0476	CbGeAlD
Metolazone—CA4—bone marrow—prostate cancer	0.00143	0.0384	CbGeAlD
Metolazone—CA5B—lymph node—prostate cancer	0.00128	0.0345	CbGeAlD
Metolazone—CA4—testis—prostate cancer	0.00122	0.0328	CbGeAlD
Metolazone—Indapamide—CYP3A4—prostate cancer	0.001	0.0972	CrCbGaD
Metolazone—CA4—lymph node—prostate cancer	0.000883	0.0238	CbGeAlD
Metolazone—Syncope—Capecitabine—prostate cancer	0.000337	0.000447	CcSEcCtD
Metolazone—Diarrhoea—Estradiol—prostate cancer	0.000336	0.000446	CcSEcCtD
Metolazone—Leukopenia—Capecitabine—prostate cancer	0.000336	0.000446	CcSEcCtD
Metolazone—Hypertension—Docetaxel—prostate cancer	0.000335	0.000444	CcSEcCtD
Metolazone—Drowsiness—Epirubicin—prostate cancer	0.000335	0.000444	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Epirubicin—prostate cancer	0.000332	0.00044	CcSEcCtD
Metolazone—Palpitations—Capecitabine—prostate cancer	0.000332	0.00044	CcSEcCtD
Metolazone—Decreased appetite—Etoposide—prostate cancer	0.000331	0.000439	CcSEcCtD
Metolazone—Chest pain—Docetaxel—prostate cancer	0.00033	0.000438	CcSEcCtD
Metolazone—Arthralgia—Docetaxel—prostate cancer	0.00033	0.000438	CcSEcCtD
Metolazone—Loss of consciousness—Capecitabine—prostate cancer	0.00033	0.000438	CcSEcCtD
Metolazone—Asthenia—Mitoxantrone—prostate cancer	0.000328	0.000436	CcSEcCtD
Metolazone—Fatigue—Etoposide—prostate cancer	0.000328	0.000436	CcSEcCtD
Metolazone—Neuropathy peripheral—Epirubicin—prostate cancer	0.000328	0.000435	CcSEcCtD
Metolazone—Cough—Capecitabine—prostate cancer	0.000328	0.000435	CcSEcCtD
Metolazone—Constipation—Etoposide—prostate cancer	0.000326	0.000432	CcSEcCtD
Metolazone—Pain—Etoposide—prostate cancer	0.000326	0.000432	CcSEcCtD
Metolazone—Dizziness—Estradiol—prostate cancer	0.000325	0.000431	CcSEcCtD
Metolazone—Hypertension—Capecitabine—prostate cancer	0.000324	0.00043	CcSEcCtD
Metolazone—Dry mouth—Docetaxel—prostate cancer	0.000323	0.000428	CcSEcCtD
Metolazone—Arthralgia—Capecitabine—prostate cancer	0.00032	0.000424	CcSEcCtD
Metolazone—Chest pain—Capecitabine—prostate cancer	0.00032	0.000424	CcSEcCtD
Metolazone—Anxiety—Capecitabine—prostate cancer	0.000319	0.000423	CcSEcCtD
Metolazone—Photosensitivity reaction—Doxorubicin—prostate cancer	0.000317	0.000421	CcSEcCtD
Metolazone—Discomfort—Capecitabine—prostate cancer	0.000316	0.000419	CcSEcCtD
Metolazone—Epistaxis—Epirubicin—prostate cancer	0.000316	0.000419	CcSEcCtD
Metolazone—Vision blurred—Prednisone—prostate cancer	0.000315	0.000418	CcSEcCtD
Metolazone—Feeling abnormal—Etoposide—prostate cancer	0.000314	0.000416	CcSEcCtD
Metolazone—Hyperglycaemia—Doxorubicin—prostate cancer	0.000313	0.000416	CcSEcCtD
Metolazone—Diarrhoea—Mitoxantrone—prostate cancer	0.000313	0.000416	CcSEcCtD
Metolazone—Dry mouth—Capecitabine—prostate cancer	0.000313	0.000415	CcSEcCtD
Metolazone—Vomiting—Estradiol—prostate cancer	0.000312	0.000414	CcSEcCtD
Metolazone—Agranulocytosis—Epirubicin—prostate cancer	0.000312	0.000414	CcSEcCtD
Metolazone—Gastrointestinal pain—Etoposide—prostate cancer	0.000311	0.000413	CcSEcCtD
Metolazone—Shock—Docetaxel—prostate cancer	0.000311	0.000413	CcSEcCtD
Metolazone—Ill-defined disorder—Prednisone—prostate cancer	0.00031	0.000412	CcSEcCtD
Metolazone—Thrombocytopenia—Docetaxel—prostate cancer	0.00031	0.000411	CcSEcCtD
Metolazone—Rash—Estradiol—prostate cancer	0.00031	0.000411	CcSEcCtD
Metolazone—Drowsiness—Doxorubicin—prostate cancer	0.00031	0.000411	CcSEcCtD
Metolazone—Dermatitis—Estradiol—prostate cancer	0.000309	0.000411	CcSEcCtD
Metolazone—Anaemia—Prednisone—prostate cancer	0.000309	0.00041	CcSEcCtD
Metolazone—Headache—Estradiol—prostate cancer	0.000308	0.000408	CcSEcCtD
Metolazone—Agitation—Prednisone—prostate cancer	0.000307	0.000408	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.000307	0.000407	CcSEcCtD
Metolazone—Neuropathy peripheral—Doxorubicin—prostate cancer	0.000304	0.000403	CcSEcCtD
Metolazone—Urticaria—Etoposide—prostate cancer	0.000303	0.000401	CcSEcCtD
Metolazone—Anorexia—Docetaxel—prostate cancer	0.000302	0.0004	CcSEcCtD
Metolazone—Malaise—Prednisone—prostate cancer	0.000302	0.0004	CcSEcCtD
Metolazone—Shock—Capecitabine—prostate cancer	0.000301	0.0004	CcSEcCtD
Metolazone—Abdominal pain—Etoposide—prostate cancer	0.000301	0.000399	CcSEcCtD
Metolazone—Vertigo—Prednisone—prostate cancer	0.0003	0.000399	CcSEcCtD
Metolazone—Hepatitis—Epirubicin—prostate cancer	0.0003	0.000399	CcSEcCtD
Metolazone—Thrombocytopenia—Capecitabine—prostate cancer	0.0003	0.000398	CcSEcCtD
Metolazone—Syncope—Prednisone—prostate cancer	0.0003	0.000398	CcSEcCtD
Metolazone—Loss of consciousness—Prednisone—prostate cancer	0.000294	0.00039	CcSEcCtD
Metolazone—Epistaxis—Doxorubicin—prostate cancer	0.000292	0.000388	CcSEcCtD
Metolazone—Anorexia—Capecitabine—prostate cancer	0.000292	0.000388	CcSEcCtD
Metolazone—Nausea—Estradiol—prostate cancer	0.000292	0.000387	CcSEcCtD
Metolazone—Vomiting—Mitoxantrone—prostate cancer	0.000291	0.000386	CcSEcCtD
Metolazone—Agranulocytosis—Doxorubicin—prostate cancer	0.000289	0.000383	CcSEcCtD
Metolazone—Hypertension—Prednisone—prostate cancer	0.000289	0.000383	CcSEcCtD
Metolazone—Rash—Mitoxantrone—prostate cancer	0.000289	0.000383	CcSEcCtD
Metolazone—Dermatitis—Mitoxantrone—prostate cancer	0.000288	0.000383	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000288	0.000383	CcSEcCtD
Metolazone—Headache—Mitoxantrone—prostate cancer	0.000287	0.000381	CcSEcCtD
Metolazone—Insomnia—Docetaxel—prostate cancer	0.000286	0.00038	CcSEcCtD
Metolazone—Arthralgia—Prednisone—prostate cancer	0.000285	0.000378	CcSEcCtD
Metolazone—Paraesthesia—Docetaxel—prostate cancer	0.000284	0.000377	CcSEcCtD
Metolazone—Erythema multiforme—Epirubicin—prostate cancer	0.000284	0.000377	CcSEcCtD
Metolazone—Anxiety—Prednisone—prostate cancer	0.000284	0.000376	CcSEcCtD
Metolazone—Somnolence—Docetaxel—prostate cancer	0.000281	0.000373	CcSEcCtD
Metolazone—Discomfort—Prednisone—prostate cancer	0.000281	0.000373	CcSEcCtD
Metolazone—Hypersensitivity—Etoposide—prostate cancer	0.000281	0.000372	CcSEcCtD
Metolazone—Tinnitus—Epirubicin—prostate cancer	0.00028	0.000372	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000279	0.00037	CcSEcCtD
Metolazone—Dyspepsia—Docetaxel—prostate cancer	0.000279	0.00037	CcSEcCtD
Metolazone—Hepatitis—Doxorubicin—prostate cancer	0.000278	0.000369	CcSEcCtD
Metolazone—Insomnia—Capecitabine—prostate cancer	0.000277	0.000368	CcSEcCtD
Metolazone—Paraesthesia—Capecitabine—prostate cancer	0.000275	0.000365	CcSEcCtD
Metolazone—Decreased appetite—Docetaxel—prostate cancer	0.000275	0.000365	CcSEcCtD
Metolazone—Asthenia—Etoposide—prostate cancer	0.000273	0.000362	CcSEcCtD
Metolazone—Fatigue—Docetaxel—prostate cancer	0.000273	0.000362	CcSEcCtD
Metolazone—Nausea—Mitoxantrone—prostate cancer	0.000272	0.000361	CcSEcCtD
Metolazone—Pain—Docetaxel—prostate cancer	0.000271	0.000359	CcSEcCtD
Metolazone—Constipation—Docetaxel—prostate cancer	0.000271	0.000359	CcSEcCtD
Metolazone—Dyspepsia—Capecitabine—prostate cancer	0.00027	0.000358	CcSEcCtD
Metolazone—Chills—Epirubicin—prostate cancer	0.00027	0.000358	CcSEcCtD
Metolazone—Pruritus—Etoposide—prostate cancer	0.000269	0.000357	CcSEcCtD
Metolazone—Shock—Prednisone—prostate cancer	0.000269	0.000356	CcSEcCtD
Metolazone—Decreased appetite—Capecitabine—prostate cancer	0.000266	0.000353	CcSEcCtD
Metolazone—Fatigue—Capecitabine—prostate cancer	0.000264	0.00035	CcSEcCtD
Metolazone—Erythema multiforme—Doxorubicin—prostate cancer	0.000263	0.000349	CcSEcCtD
Metolazone—Pain—Capecitabine—prostate cancer	0.000262	0.000348	CcSEcCtD
Metolazone—Constipation—Capecitabine—prostate cancer	0.000262	0.000348	CcSEcCtD
Metolazone—Feeling abnormal—Docetaxel—prostate cancer	0.000261	0.000346	CcSEcCtD
Metolazone—Diarrhoea—Etoposide—prostate cancer	0.000261	0.000346	CcSEcCtD
Metolazone—Anorexia—Prednisone—prostate cancer	0.00026	0.000345	CcSEcCtD
Metolazone—Tinnitus—Doxorubicin—prostate cancer	0.000259	0.000344	CcSEcCtD
Metolazone—Gastrointestinal pain—Docetaxel—prostate cancer	0.000259	0.000343	CcSEcCtD
Metolazone—Flatulence—Epirubicin—prostate cancer	0.000258	0.000342	CcSEcCtD
Metolazone—Tension—Epirubicin—prostate cancer	0.000257	0.000341	CcSEcCtD
Metolazone—Dysgeusia—Epirubicin—prostate cancer	0.000256	0.00034	CcSEcCtD
Metolazone—Nervousness—Epirubicin—prostate cancer	0.000254	0.000337	CcSEcCtD
Metolazone—Back pain—Epirubicin—prostate cancer	0.000253	0.000336	CcSEcCtD
Metolazone—Feeling abnormal—Capecitabine—prostate cancer	0.000252	0.000335	CcSEcCtD
Metolazone—Dizziness—Etoposide—prostate cancer	0.000252	0.000334	CcSEcCtD
Metolazone—Muscle spasms—Epirubicin—prostate cancer	0.000251	0.000334	CcSEcCtD
Metolazone—Gastrointestinal pain—Capecitabine—prostate cancer	0.000251	0.000332	CcSEcCtD
Metolazone—Abdominal pain—Docetaxel—prostate cancer	0.00025	0.000332	CcSEcCtD
Metolazone—Chills—Doxorubicin—prostate cancer	0.000249	0.000331	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000249	0.00033	CcSEcCtD
Metolazone—Insomnia—Prednisone—prostate cancer	0.000247	0.000328	CcSEcCtD
Metolazone—Vision blurred—Epirubicin—prostate cancer	0.000246	0.000327	CcSEcCtD
Metolazone—Paraesthesia—Prednisone—prostate cancer	0.000245	0.000325	CcSEcCtD
Metolazone—Urticaria—Capecitabine—prostate cancer	0.000243	0.000323	CcSEcCtD
Metolazone—Ill-defined disorder—Epirubicin—prostate cancer	0.000243	0.000322	CcSEcCtD
Metolazone—Abdominal pain—Capecitabine—prostate cancer	0.000242	0.000321	CcSEcCtD
Metolazone—Vomiting—Etoposide—prostate cancer	0.000242	0.000321	CcSEcCtD
Metolazone—Anaemia—Epirubicin—prostate cancer	0.000242	0.000321	CcSEcCtD
Metolazone—Agitation—Epirubicin—prostate cancer	0.00024	0.000319	CcSEcCtD
Metolazone—Dyspepsia—Prednisone—prostate cancer	0.00024	0.000319	CcSEcCtD
Metolazone—Rash—Etoposide—prostate cancer	0.00024	0.000319	CcSEcCtD
Metolazone—Dermatitis—Etoposide—prostate cancer	0.00024	0.000318	CcSEcCtD
Metolazone—Headache—Etoposide—prostate cancer	0.000239	0.000317	CcSEcCtD
Metolazone—Flatulence—Doxorubicin—prostate cancer	0.000238	0.000316	CcSEcCtD
Metolazone—Tension—Doxorubicin—prostate cancer	0.000237	0.000315	CcSEcCtD
Metolazone—Decreased appetite—Prednisone—prostate cancer	0.000237	0.000315	CcSEcCtD
Metolazone—Dysgeusia—Doxorubicin—prostate cancer	0.000237	0.000314	CcSEcCtD
Metolazone—Malaise—Epirubicin—prostate cancer	0.000236	0.000313	CcSEcCtD
Metolazone—Fatigue—Prednisone—prostate cancer	0.000235	0.000312	CcSEcCtD
Metolazone—Nervousness—Doxorubicin—prostate cancer	0.000235	0.000312	CcSEcCtD
Metolazone—Vertigo—Epirubicin—prostate cancer	0.000235	0.000312	CcSEcCtD
Metolazone—Syncope—Epirubicin—prostate cancer	0.000235	0.000311	CcSEcCtD
Metolazone—Leukopenia—Epirubicin—prostate cancer	0.000234	0.000311	CcSEcCtD
Metolazone—Back pain—Doxorubicin—prostate cancer	0.000234	0.000311	CcSEcCtD
Metolazone—Constipation—Prednisone—prostate cancer	0.000233	0.00031	CcSEcCtD
Metolazone—Hypersensitivity—Docetaxel—prostate cancer	0.000233	0.000309	CcSEcCtD
Metolazone—Muscle spasms—Doxorubicin—prostate cancer	0.000233	0.000309	CcSEcCtD
Metolazone—Palpitations—Epirubicin—prostate cancer	0.000231	0.000307	CcSEcCtD
Metolazone—Loss of consciousness—Epirubicin—prostate cancer	0.00023	0.000305	CcSEcCtD
Metolazone—Cough—Epirubicin—prostate cancer	0.000228	0.000303	CcSEcCtD
Metolazone—Vision blurred—Doxorubicin—prostate cancer	0.000228	0.000303	CcSEcCtD
Metolazone—Asthenia—Docetaxel—prostate cancer	0.000227	0.000301	CcSEcCtD
Metolazone—Nausea—Etoposide—prostate cancer	0.000226	0.0003	CcSEcCtD
Metolazone—Hypertension—Epirubicin—prostate cancer	0.000226	0.0003	CcSEcCtD
Metolazone—Hypersensitivity—Capecitabine—prostate cancer	0.000226	0.0003	CcSEcCtD
Metolazone—Feeling abnormal—Prednisone—prostate cancer	0.000225	0.000298	CcSEcCtD
Metolazone—Ill-defined disorder—Doxorubicin—prostate cancer	0.000225	0.000298	CcSEcCtD
Metolazone—Pruritus—Docetaxel—prostate cancer	0.000224	0.000297	CcSEcCtD
Metolazone—Anaemia—Doxorubicin—prostate cancer	0.000224	0.000297	CcSEcCtD
Metolazone—Gastrointestinal pain—Prednisone—prostate cancer	0.000223	0.000296	CcSEcCtD
Metolazone—Arthralgia—Epirubicin—prostate cancer	0.000223	0.000295	CcSEcCtD
Metolazone—Chest pain—Epirubicin—prostate cancer	0.000223	0.000295	CcSEcCtD
Metolazone—Agitation—Doxorubicin—prostate cancer	0.000222	0.000295	CcSEcCtD
Metolazone—Anxiety—Epirubicin—prostate cancer	0.000222	0.000294	CcSEcCtD
Metolazone—Discomfort—Epirubicin—prostate cancer	0.00022	0.000292	CcSEcCtD
Metolazone—Asthenia—Capecitabine—prostate cancer	0.00022	0.000292	CcSEcCtD
Metolazone—Malaise—Doxorubicin—prostate cancer	0.000218	0.00029	CcSEcCtD
Metolazone—Dry mouth—Epirubicin—prostate cancer	0.000218	0.000289	CcSEcCtD
Metolazone—Vertigo—Doxorubicin—prostate cancer	0.000217	0.000288	CcSEcCtD
Metolazone—Syncope—Doxorubicin—prostate cancer	0.000217	0.000288	CcSEcCtD
Metolazone—Urticaria—Prednisone—prostate cancer	0.000217	0.000288	CcSEcCtD
Metolazone—Pruritus—Capecitabine—prostate cancer	0.000217	0.000288	CcSEcCtD
Metolazone—Leukopenia—Doxorubicin—prostate cancer	0.000217	0.000287	CcSEcCtD
Metolazone—Diarrhoea—Docetaxel—prostate cancer	0.000217	0.000287	CcSEcCtD
Metolazone—Abdominal pain—Prednisone—prostate cancer	0.000216	0.000286	CcSEcCtD
Metolazone—Palpitations—Doxorubicin—prostate cancer	0.000214	0.000284	CcSEcCtD
Metolazone—Loss of consciousness—Doxorubicin—prostate cancer	0.000213	0.000282	CcSEcCtD
Metolazone—Cough—Doxorubicin—prostate cancer	0.000211	0.00028	CcSEcCtD
Metolazone—Shock—Epirubicin—prostate cancer	0.00021	0.000279	CcSEcCtD
Metolazone—Diarrhoea—Capecitabine—prostate cancer	0.00021	0.000278	CcSEcCtD
Metolazone—Dizziness—Docetaxel—prostate cancer	0.000209	0.000278	CcSEcCtD
Metolazone—Thrombocytopenia—Epirubicin—prostate cancer	0.000209	0.000277	CcSEcCtD
Metolazone—Hypertension—Doxorubicin—prostate cancer	0.000209	0.000277	CcSEcCtD
Metolazone—Arthralgia—Doxorubicin—prostate cancer	0.000206	0.000273	CcSEcCtD
Metolazone—Chest pain—Doxorubicin—prostate cancer	0.000206	0.000273	CcSEcCtD
Metolazone—Anxiety—Doxorubicin—prostate cancer	0.000205	0.000272	CcSEcCtD
Metolazone—Discomfort—Doxorubicin—prostate cancer	0.000204	0.00027	CcSEcCtD
Metolazone—Anorexia—Epirubicin—prostate cancer	0.000203	0.00027	CcSEcCtD
Metolazone—Dizziness—Capecitabine—prostate cancer	0.000203	0.000269	CcSEcCtD
Metolazone—Dry mouth—Doxorubicin—prostate cancer	0.000201	0.000267	CcSEcCtD
Metolazone—Vomiting—Docetaxel—prostate cancer	0.000201	0.000267	CcSEcCtD
Metolazone—Hypersensitivity—Prednisone—prostate cancer	0.000201	0.000267	CcSEcCtD
Metolazone—Rash—Docetaxel—prostate cancer	0.0002	0.000265	CcSEcCtD
Metolazone—Dermatitis—Docetaxel—prostate cancer	0.000199	0.000265	CcSEcCtD
Metolazone—Headache—Docetaxel—prostate cancer	0.000198	0.000263	CcSEcCtD
Metolazone—Asthenia—Prednisone—prostate cancer	0.000196	0.00026	CcSEcCtD
Metolazone—Vomiting—Capecitabine—prostate cancer	0.000195	0.000258	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000194	0.000258	CcSEcCtD
Metolazone—Shock—Doxorubicin—prostate cancer	0.000194	0.000258	CcSEcCtD
Metolazone—Thrombocytopenia—Doxorubicin—prostate cancer	0.000193	0.000257	CcSEcCtD
Metolazone—Rash—Capecitabine—prostate cancer	0.000193	0.000256	CcSEcCtD
Metolazone—Pruritus—Prednisone—prostate cancer	0.000193	0.000256	CcSEcCtD
Metolazone—Insomnia—Epirubicin—prostate cancer	0.000193	0.000256	CcSEcCtD
Metolazone—Dermatitis—Capecitabine—prostate cancer	0.000193	0.000256	CcSEcCtD
Metolazone—Headache—Capecitabine—prostate cancer	0.000192	0.000255	CcSEcCtD
Metolazone—Paraesthesia—Epirubicin—prostate cancer	0.000192	0.000254	CcSEcCtD
Metolazone—Somnolence—Epirubicin—prostate cancer	0.00019	0.000252	CcSEcCtD
Metolazone—Anorexia—Doxorubicin—prostate cancer	0.000188	0.00025	CcSEcCtD
Metolazone—Nausea—Docetaxel—prostate cancer	0.000188	0.000249	CcSEcCtD
Metolazone—Dyspepsia—Epirubicin—prostate cancer	0.000188	0.000249	CcSEcCtD
Metolazone—Diarrhoea—Prednisone—prostate cancer	0.000187	0.000248	CcSEcCtD
Metolazone—Decreased appetite—Epirubicin—prostate cancer	0.000186	0.000246	CcSEcCtD
Metolazone—Fatigue—Epirubicin—prostate cancer	0.000184	0.000244	CcSEcCtD
Metolazone—Pain—Epirubicin—prostate cancer	0.000183	0.000242	CcSEcCtD
Metolazone—Constipation—Epirubicin—prostate cancer	0.000183	0.000242	CcSEcCtD
Metolazone—Nausea—Capecitabine—prostate cancer	0.000182	0.000241	CcSEcCtD
Metolazone—Dizziness—Prednisone—prostate cancer	0.00018	0.000239	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.00018	0.000239	CcSEcCtD
Metolazone—Insomnia—Doxorubicin—prostate cancer	0.000179	0.000237	CcSEcCtD
Metolazone—Paraesthesia—Doxorubicin—prostate cancer	0.000177	0.000235	CcSEcCtD
Metolazone—Feeling abnormal—Epirubicin—prostate cancer	0.000176	0.000233	CcSEcCtD
Metolazone—Somnolence—Doxorubicin—prostate cancer	0.000176	0.000233	CcSEcCtD
Metolazone—Gastrointestinal pain—Epirubicin—prostate cancer	0.000175	0.000232	CcSEcCtD
Metolazone—Dyspepsia—Doxorubicin—prostate cancer	0.000174	0.000231	CcSEcCtD
Metolazone—Vomiting—Prednisone—prostate cancer	0.000174	0.00023	CcSEcCtD
Metolazone—Rash—Prednisone—prostate cancer	0.000172	0.000228	CcSEcCtD
Metolazone—Dermatitis—Prednisone—prostate cancer	0.000172	0.000228	CcSEcCtD
Metolazone—Decreased appetite—Doxorubicin—prostate cancer	0.000172	0.000228	CcSEcCtD
Metolazone—Headache—Prednisone—prostate cancer	0.000171	0.000227	CcSEcCtD
Metolazone—Fatigue—Doxorubicin—prostate cancer	0.00017	0.000226	CcSEcCtD
Metolazone—Urticaria—Epirubicin—prostate cancer	0.00017	0.000225	CcSEcCtD
Metolazone—Pain—Doxorubicin—prostate cancer	0.000169	0.000224	CcSEcCtD
Metolazone—Constipation—Doxorubicin—prostate cancer	0.000169	0.000224	CcSEcCtD
Metolazone—Abdominal pain—Epirubicin—prostate cancer	0.000169	0.000224	CcSEcCtD
Metolazone—Feeling abnormal—Doxorubicin—prostate cancer	0.000163	0.000216	CcSEcCtD
Metolazone—Nausea—Prednisone—prostate cancer	0.000162	0.000215	CcSEcCtD
Metolazone—Gastrointestinal pain—Doxorubicin—prostate cancer	0.000162	0.000214	CcSEcCtD
Metolazone—Hypersensitivity—Epirubicin—prostate cancer	0.000157	0.000209	CcSEcCtD
Metolazone—Urticaria—Doxorubicin—prostate cancer	0.000157	0.000208	CcSEcCtD
Metolazone—Abdominal pain—Doxorubicin—prostate cancer	0.000156	0.000207	CcSEcCtD
Metolazone—Asthenia—Epirubicin—prostate cancer	0.000153	0.000203	CcSEcCtD
Metolazone—Pruritus—Epirubicin—prostate cancer	0.000151	0.0002	CcSEcCtD
Metolazone—Diarrhoea—Epirubicin—prostate cancer	0.000146	0.000194	CcSEcCtD
Metolazone—Hypersensitivity—Doxorubicin—prostate cancer	0.000146	0.000193	CcSEcCtD
Metolazone—CA7—Metabolism—NCOA2—prostate cancer	0.000144	0.000725	CbGpPWpGaD
Metolazone—CA5B—Metabolism—NCOA2—prostate cancer	0.000144	0.000725	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CYP2E1—prostate cancer	0.000144	0.000724	CbGpPWpGaD
Metolazone—CA4—Metabolism—P4HB—prostate cancer	0.000143	0.00072	CbGpPWpGaD
Metolazone—CA12—Metabolism—AKR1C3—prostate cancer	0.000143	0.000716	CbGpPWpGaD
Metolazone—CA5A—Metabolism—NQO1—prostate cancer	0.000142	0.000716	CbGpPWpGaD
Metolazone—CA12—Metabolism—PRKACB—prostate cancer	0.000142	0.000713	CbGpPWpGaD
Metolazone—Asthenia—Doxorubicin—prostate cancer	0.000142	0.000188	CcSEcCtD
Metolazone—Dizziness—Epirubicin—prostate cancer	0.000141	0.000187	CcSEcCtD
Metolazone—CA5A—Metabolism—TH—prostate cancer	0.00014	0.000706	CbGpPWpGaD
Metolazone—CA12—Metabolism—CYP17A1—prostate cancer	0.00014	0.000705	CbGpPWpGaD
Metolazone—Pruritus—Doxorubicin—prostate cancer	0.00014	0.000185	CcSEcCtD
Metolazone—CA4—Metabolism—SLC22A1—prostate cancer	0.000139	0.000701	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CYP3A4—prostate cancer	0.000139	0.000698	CbGpPWpGaD
Metolazone—CA9—Metabolism—HSD3B1—prostate cancer	0.000138	0.000695	CbGpPWpGaD
Metolazone—CA9—Metabolism—SLC22A3—prostate cancer	0.000138	0.000695	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—CXCL8—prostate cancer	0.000138	0.000694	CbGpPWpGaD
Metolazone—CA5B—Metabolism—SLC5A5—prostate cancer	0.000138	0.000692	CbGpPWpGaD
Metolazone—CA7—Metabolism—SLC5A5—prostate cancer	0.000138	0.000692	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CYP1B1—prostate cancer	0.000137	0.000686	CbGpPWpGaD
Metolazone—CA4—Metabolism—SULT2A1—prostate cancer	0.000136	0.000683	CbGpPWpGaD
Metolazone—Vomiting—Epirubicin—prostate cancer	0.000136	0.00018	CcSEcCtD
Metolazone—Diarrhoea—Doxorubicin—prostate cancer	0.000135	0.000179	CcSEcCtD
Metolazone—CA9—Cellular responses to stress—CDKN1B—prostate cancer	0.000135	0.000678	CbGpPWpGaD
Metolazone—Rash—Epirubicin—prostate cancer	0.000135	0.000179	CcSEcCtD
Metolazone—CA5B—Metabolism—CYP2E1—prostate cancer	0.000134	0.000676	CbGpPWpGaD
Metolazone—CA7—Metabolism—CYP2E1—prostate cancer	0.000134	0.000676	CbGpPWpGaD
Metolazone—Dermatitis—Epirubicin—prostate cancer	0.000134	0.000178	CcSEcCtD
Metolazone—Headache—Epirubicin—prostate cancer	0.000134	0.000177	CcSEcCtD
Metolazone—CA12—Metabolism—NCOA2—prostate cancer	0.000134	0.000672	CbGpPWpGaD
Metolazone—CA4—Metabolism—MED12—prostate cancer	0.000134	0.000672	CbGpPWpGaD
Metolazone—CA5B—Metabolism—NQO1—prostate cancer	0.000133	0.000668	CbGpPWpGaD
Metolazone—CA7—Metabolism—NQO1—prostate cancer	0.000133	0.000668	CbGpPWpGaD
Metolazone—CA4—Metabolism—GNG5—prostate cancer	0.000133	0.000667	CbGpPWpGaD
Metolazone—CA9—Metabolism—TBXAS1—prostate cancer	0.000133	0.000666	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTA4—prostate cancer	0.000133	0.000666	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GGT1—prostate cancer	0.000132	0.000665	CbGpPWpGaD
Metolazone—CA7—Metabolism—TH—prostate cancer	0.000131	0.000659	CbGpPWpGaD
Metolazone—CA5B—Metabolism—TH—prostate cancer	0.000131	0.000659	CbGpPWpGaD
Metolazone—Dizziness—Doxorubicin—prostate cancer	0.000131	0.000173	CcSEcCtD
Metolazone—CA5A—Metabolism—NCOA1—prostate cancer	0.00013	0.000655	CbGpPWpGaD
Metolazone—CA7—Metabolism—CYP3A4—prostate cancer	0.00013	0.000652	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CYP3A4—prostate cancer	0.00013	0.000652	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTA2—prostate cancer	0.000129	0.000649	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CYP19A1—prostate cancer	0.000128	0.000645	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000128	0.000645	CbGpPWpGaD
Metolazone—CA4—Metabolism—NCOA3—prostate cancer	0.000128	0.000642	CbGpPWpGaD
Metolazone—CA12—Metabolism—SLC5A5—prostate cancer	0.000128	0.000641	CbGpPWpGaD
Metolazone—CA9—Metabolism—ABCG5—prostate cancer	0.000128	0.000641	CbGpPWpGaD
Metolazone—CA9—Metabolism—SULT1A1—prostate cancer	0.000128	0.000641	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CYP1B1—prostate cancer	0.000127	0.000641	CbGpPWpGaD
Metolazone—CA7—Metabolism—CYP1B1—prostate cancer	0.000127	0.000641	CbGpPWpGaD
Metolazone—Nausea—Epirubicin—prostate cancer	0.000127	0.000168	CcSEcCtD
Metolazone—Vomiting—Doxorubicin—prostate cancer	0.000126	0.000167	CcSEcCtD
Metolazone—CA12—Metabolism—CYP2E1—prostate cancer	0.000125	0.000626	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTA1—prostate cancer	0.000125	0.000626	CbGpPWpGaD
Metolazone—Rash—Doxorubicin—prostate cancer	0.000125	0.000165	CcSEcCtD
Metolazone—CA9—Cellular responses to stress—CDKN1A—prostate cancer	0.000124	0.000625	CbGpPWpGaD
Metolazone—Dermatitis—Doxorubicin—prostate cancer	0.000124	0.000165	CcSEcCtD
Metolazone—CA5A—Metabolism—RXRA—prostate cancer	0.000124	0.000623	CbGpPWpGaD
Metolazone—Headache—Doxorubicin—prostate cancer	0.000124	0.000164	CcSEcCtD
Metolazone—CA7—Metabolism—GGT1—prostate cancer	0.000123	0.000621	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GGT1—prostate cancer	0.000123	0.000621	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTO1—prostate cancer	0.000123	0.000619	CbGpPWpGaD
Metolazone—CA9—Metabolism—HSD3B2—prostate cancer	0.000123	0.000619	CbGpPWpGaD
Metolazone—CA12—Metabolism—NQO1—prostate cancer	0.000123	0.000619	CbGpPWpGaD
Metolazone—CA9—Metabolism—NAT2—prostate cancer	0.000123	0.000619	CbGpPWpGaD
Metolazone—CA4—Metabolism—HPGDS—prostate cancer	0.000122	0.000613	CbGpPWpGaD
Metolazone—CA5B—Metabolism—NCOA1—prostate cancer	0.000122	0.000611	CbGpPWpGaD
Metolazone—CA7—Metabolism—NCOA1—prostate cancer	0.000122	0.000611	CbGpPWpGaD
Metolazone—CA12—Metabolism—TH—prostate cancer	0.000121	0.00061	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP2C19—prostate cancer	0.000121	0.000609	CbGpPWpGaD
Metolazone—CA12—Metabolism—CYP3A4—prostate cancer	0.00012	0.000604	CbGpPWpGaD
Metolazone—CA7—Metabolism—CYP19A1—prostate cancer	0.00012	0.000602	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CYP19A1—prostate cancer	0.00012	0.000602	CbGpPWpGaD
Metolazone—CA5A—Metabolism—COMT—prostate cancer	0.000119	0.0006	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GSTP1—prostate cancer	0.000119	0.000597	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—EP300—prostate cancer	0.000118	0.000595	CbGpPWpGaD
Metolazone—CA4—Metabolism—GSTT1—prostate cancer	0.000118	0.000594	CbGpPWpGaD
Metolazone—CA4—Metabolism—ACHE—prostate cancer	0.000118	0.000594	CbGpPWpGaD
Metolazone—CA9—Metabolism—PLCB2—prostate cancer	0.000118	0.000594	CbGpPWpGaD
Metolazone—CA12—Metabolism—CYP1B1—prostate cancer	0.000118	0.000594	CbGpPWpGaD
Metolazone—CA9—Metabolism—LRP2—prostate cancer	0.000118	0.000594	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP2C18—prostate cancer	0.000118	0.000594	CbGpPWpGaD
Metolazone—Nausea—Doxorubicin—prostate cancer	0.000117	0.000156	CcSEcCtD
Metolazone—CA5A—Metabolism—ITPR1—prostate cancer	0.000117	0.000588	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP2A6—prostate cancer	0.000117	0.000587	CbGpPWpGaD
Metolazone—CA9—Metabolism—P4HB—prostate cancer	0.000116	0.000582	CbGpPWpGaD
Metolazone—CA7—Metabolism—RXRA—prostate cancer	0.000116	0.000581	CbGpPWpGaD
Metolazone—CA5B—Metabolism—RXRA—prostate cancer	0.000116	0.000581	CbGpPWpGaD
Metolazone—CA12—Metabolism—GGT1—prostate cancer	0.000114	0.000575	CbGpPWpGaD
Metolazone—CA4—Metabolism—AKR1C3—prostate cancer	0.000114	0.000571	CbGpPWpGaD
Metolazone—CA4—Metabolism—PRKACB—prostate cancer	0.000113	0.000568	CbGpPWpGaD
Metolazone—CA9—Metabolism—SLC22A1—prostate cancer	0.000113	0.000566	CbGpPWpGaD
Metolazone—CA12—Metabolism—NCOA1—prostate cancer	0.000113	0.000566	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—VEGFA—prostate cancer	0.000112	0.000564	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP17A1—prostate cancer	0.000112	0.000562	CbGpPWpGaD
Metolazone—CA7—Metabolism—COMT—prostate cancer	0.000111	0.00056	CbGpPWpGaD
Metolazone—CA5B—Metabolism—COMT—prostate cancer	0.000111	0.00056	CbGpPWpGaD
Metolazone—CA12—Metabolism—CYP19A1—prostate cancer	0.000111	0.000558	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—STAT3—prostate cancer	0.000111	0.000558	CbGpPWpGaD
Metolazone—CA7—Metabolism—GSTP1—prostate cancer	0.000111	0.000557	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GSTP1—prostate cancer	0.000111	0.000557	CbGpPWpGaD
Metolazone—CA5A—Metabolism—TYMS—prostate cancer	0.00011	0.000555	CbGpPWpGaD
Metolazone—CA9—Metabolism—SULT2A1—prostate cancer	0.00011	0.000552	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GSTM1—prostate cancer	0.000109	0.000549	CbGpPWpGaD
Metolazone—CA7—Metabolism—ITPR1—prostate cancer	0.000109	0.000549	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ITPR1—prostate cancer	0.000109	0.000549	CbGpPWpGaD
Metolazone—CA9—Metabolism—MED12—prostate cancer	0.000108	0.000543	CbGpPWpGaD
Metolazone—CA9—Metabolism—GNG5—prostate cancer	0.000107	0.000539	CbGpPWpGaD
Metolazone—CA12—Metabolism—RXRA—prostate cancer	0.000107	0.000539	CbGpPWpGaD
Metolazone—CA5A—Metabolism—LPL—prostate cancer	0.000107	0.000539	CbGpPWpGaD
Metolazone—CA4—Metabolism—NCOA2—prostate cancer	0.000107	0.000536	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CYP1A1—prostate cancer	0.000103	0.00052	CbGpPWpGaD
Metolazone—CA12—Metabolism—COMT—prostate cancer	0.000103	0.000519	CbGpPWpGaD
Metolazone—CA9—Metabolism—NCOA3—prostate cancer	0.000103	0.000519	CbGpPWpGaD
Metolazone—CA7—Metabolism—TYMS—prostate cancer	0.000103	0.000518	CbGpPWpGaD
Metolazone—CA5B—Metabolism—TYMS—prostate cancer	0.000103	0.000518	CbGpPWpGaD
Metolazone—CA12—Metabolism—GSTP1—prostate cancer	0.000103	0.000516	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ERCC2—prostate cancer	0.000103	0.000516	CbGpPWpGaD
Metolazone—CA7—Metabolism—GSTM1—prostate cancer	0.000102	0.000512	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GSTM1—prostate cancer	0.000102	0.000512	CbGpPWpGaD
Metolazone—CA4—Metabolism—SLC5A5—prostate cancer	0.000102	0.000511	CbGpPWpGaD
Metolazone—CA12—Metabolism—ITPR1—prostate cancer	0.000101	0.000508	CbGpPWpGaD
Metolazone—CA7—Metabolism—LPL—prostate cancer	0.0001	0.000503	CbGpPWpGaD
Metolazone—CA5B—Metabolism—LPL—prostate cancer	0.0001	0.000503	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP2E1—prostate cancer	9.94e-05	0.000499	CbGpPWpGaD
Metolazone—CA9—Metabolism—HPGDS—prostate cancer	9.85e-05	0.000495	CbGpPWpGaD
Metolazone—CA4—Metabolism—NQO1—prostate cancer	9.82e-05	0.000494	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP2C19—prostate cancer	9.79e-05	0.000492	CbGpPWpGaD
Metolazone—CA4—Metabolism—TH—prostate cancer	9.68e-05	0.000487	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CYP1A1—prostate cancer	9.66e-05	0.000486	CbGpPWpGaD
Metolazone—CA7—Metabolism—CYP1A1—prostate cancer	9.66e-05	0.000486	CbGpPWpGaD
Metolazone—CA5A—Metabolism—MTHFR—prostate cancer	9.65e-05	0.000485	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ERCC2—prostate cancer	9.58e-05	0.000482	CbGpPWpGaD
Metolazone—CA7—Metabolism—ERCC2—prostate cancer	9.58e-05	0.000482	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP3A4—prostate cancer	9.58e-05	0.000482	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTT1—prostate cancer	9.55e-05	0.00048	CbGpPWpGaD
Metolazone—CA9—Metabolism—ACHE—prostate cancer	9.55e-05	0.00048	CbGpPWpGaD
Metolazone—CA12—Metabolism—TYMS—prostate cancer	9.55e-05	0.00048	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PPARA—prostate cancer	9.47e-05	0.000476	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP2A6—prostate cancer	9.44e-05	0.000475	CbGpPWpGaD
Metolazone—CA12—Metabolism—GSTM1—prostate cancer	9.44e-05	0.000475	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP1B1—prostate cancer	9.42e-05	0.000473	CbGpPWpGaD
Metolazone—CA12—Metabolism—LPL—prostate cancer	9.27e-05	0.000466	CbGpPWpGaD
Metolazone—CA9—Metabolism—AKR1C3—prostate cancer	9.18e-05	0.000462	CbGpPWpGaD
Metolazone—CA9—Metabolism—PRKACB—prostate cancer	9.14e-05	0.000459	CbGpPWpGaD
Metolazone—CA4—Metabolism—GGT1—prostate cancer	9.12e-05	0.000459	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP17A1—prostate cancer	9.04e-05	0.000454	CbGpPWpGaD
Metolazone—CA7—Metabolism—MTHFR—prostate cancer	9.01e-05	0.000453	CbGpPWpGaD
Metolazone—CA5B—Metabolism—MTHFR—prostate cancer	9.01e-05	0.000453	CbGpPWpGaD
Metolazone—CA4—Metabolism—NCOA1—prostate cancer	8.99e-05	0.000452	CbGpPWpGaD
Metolazone—CA12—Metabolism—CYP1A1—prostate cancer	8.95e-05	0.00045	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CAV1—prostate cancer	8.9e-05	0.000447	CbGpPWpGaD
Metolazone—CA12—Metabolism—ERCC2—prostate cancer	8.88e-05	0.000446	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP19A1—prostate cancer	8.86e-05	0.000445	CbGpPWpGaD
Metolazone—CA7—Metabolism—PPARA—prostate cancer	8.84e-05	0.000444	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PPARA—prostate cancer	8.84e-05	0.000444	CbGpPWpGaD
Metolazone—CA9—Metabolism—NCOA2—prostate cancer	8.62e-05	0.000433	CbGpPWpGaD
Metolazone—CA4—Metabolism—RXRA—prostate cancer	8.55e-05	0.00043	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—TP53—prostate cancer	8.47e-05	0.000426	CbGpPWpGaD
Metolazone—CA12—Metabolism—MTHFR—prostate cancer	8.34e-05	0.000419	CbGpPWpGaD
Metolazone—CA7—Metabolism—CAV1—prostate cancer	8.31e-05	0.000418	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CAV1—prostate cancer	8.31e-05	0.000418	CbGpPWpGaD
Metolazone—CA4—Metabolism—COMT—prostate cancer	8.23e-05	0.000414	CbGpPWpGaD
Metolazone—CA9—Metabolism—SLC5A5—prostate cancer	8.22e-05	0.000413	CbGpPWpGaD
Metolazone—CA4—Metabolism—GSTP1—prostate cancer	8.19e-05	0.000412	CbGpPWpGaD
Metolazone—CA12—Metabolism—PPARA—prostate cancer	8.19e-05	0.000411	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PIK3CG—prostate cancer	8.11e-05	0.000407	CbGpPWpGaD
Metolazone—CA4—Metabolism—ITPR1—prostate cancer	8.06e-05	0.000405	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP2E1—prostate cancer	8.03e-05	0.000404	CbGpPWpGaD
Metolazone—CA9—Metabolism—NQO1—prostate cancer	7.94e-05	0.000399	CbGpPWpGaD
Metolazone—CA9—Metabolism—TH—prostate cancer	7.82e-05	0.000393	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—IL6—prostate cancer	7.76e-05	0.00039	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP3A4—prostate cancer	7.74e-05	0.000389	CbGpPWpGaD
Metolazone—CA12—Metabolism—CAV1—prostate cancer	7.7e-05	0.000387	CbGpPWpGaD
Metolazone—CA5A—Metabolism—INS—prostate cancer	7.67e-05	0.000386	CbGpPWpGaD
Metolazone—CA4—Metabolism—TYMS—prostate cancer	7.62e-05	0.000383	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP1B1—prostate cancer	7.61e-05	0.000383	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PIK3CG—prostate cancer	7.57e-05	0.00038	CbGpPWpGaD
Metolazone—CA7—Metabolism—PIK3CG—prostate cancer	7.57e-05	0.00038	CbGpPWpGaD
Metolazone—CA4—Metabolism—GSTM1—prostate cancer	7.53e-05	0.000378	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CREBBP—prostate cancer	7.52e-05	0.000378	CbGpPWpGaD
Metolazone—CA4—Metabolism—LPL—prostate cancer	7.39e-05	0.000371	CbGpPWpGaD
Metolazone—CA9—Metabolism—GGT1—prostate cancer	7.37e-05	0.00037	CbGpPWpGaD
Metolazone—CA9—Metabolism—NCOA1—prostate cancer	7.26e-05	0.000365	CbGpPWpGaD
Metolazone—CA7—Metabolism—INS—prostate cancer	7.16e-05	0.00036	CbGpPWpGaD
Metolazone—CA5B—Metabolism—INS—prostate cancer	7.16e-05	0.00036	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP19A1—prostate cancer	7.16e-05	0.00036	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP1A1—prostate cancer	7.14e-05	0.000359	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PIK3CD—prostate cancer	7.13e-05	0.000358	CbGpPWpGaD
Metolazone—CA4—Metabolism—ERCC2—prostate cancer	7.08e-05	0.000356	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CREBBP—prostate cancer	7.02e-05	0.000353	CbGpPWpGaD
Metolazone—CA7—Metabolism—CREBBP—prostate cancer	7.02e-05	0.000353	CbGpPWpGaD
Metolazone—CA12—Metabolism—PIK3CG—prostate cancer	7.01e-05	0.000352	CbGpPWpGaD
Metolazone—CA9—Metabolism—RXRA—prostate cancer	6.91e-05	0.000347	CbGpPWpGaD
Metolazone—CA5A—Metabolism—NOS3—prostate cancer	6.73e-05	0.000338	CbGpPWpGaD
Metolazone—CA4—Metabolism—MTHFR—prostate cancer	6.65e-05	0.000334	CbGpPWpGaD
Metolazone—CA7—Metabolism—PIK3CD—prostate cancer	6.65e-05	0.000334	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PIK3CD—prostate cancer	6.65e-05	0.000334	CbGpPWpGaD
Metolazone—CA9—Metabolism—COMT—prostate cancer	6.65e-05	0.000334	CbGpPWpGaD
Metolazone—CA12—Metabolism—INS—prostate cancer	6.64e-05	0.000334	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTP1—prostate cancer	6.62e-05	0.000333	CbGpPWpGaD
Metolazone—CA4—Metabolism—PPARA—prostate cancer	6.53e-05	0.000328	CbGpPWpGaD
Metolazone—CA9—Metabolism—ITPR1—prostate cancer	6.51e-05	0.000327	CbGpPWpGaD
Metolazone—CA12—Metabolism—CREBBP—prostate cancer	6.5e-05	0.000327	CbGpPWpGaD
Metolazone—CA5B—Metabolism—NOS3—prostate cancer	6.28e-05	0.000316	CbGpPWpGaD
Metolazone—CA7—Metabolism—NOS3—prostate cancer	6.28e-05	0.000316	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PIK3CB—prostate cancer	6.21e-05	0.000312	CbGpPWpGaD
Metolazone—CA12—Metabolism—PIK3CD—prostate cancer	6.16e-05	0.00031	CbGpPWpGaD
Metolazone—CA9—Metabolism—TYMS—prostate cancer	6.16e-05	0.000309	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PTGS2—prostate cancer	6.15e-05	0.000309	CbGpPWpGaD
Metolazone—CA4—Metabolism—CAV1—prostate cancer	6.14e-05	0.000309	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTM1—prostate cancer	6.08e-05	0.000306	CbGpPWpGaD
Metolazone—CA9—Metabolism—LPL—prostate cancer	5.97e-05	0.0003	CbGpPWpGaD
Metolazone—CA12—Metabolism—NOS3—prostate cancer	5.82e-05	0.000293	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PIK3CB—prostate cancer	5.8e-05	0.000291	CbGpPWpGaD
Metolazone—CA7—Metabolism—PIK3CB—prostate cancer	5.8e-05	0.000291	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP1A1—prostate cancer	5.77e-05	0.00029	CbGpPWpGaD
Metolazone—CA7—Metabolism—PTGS2—prostate cancer	5.75e-05	0.000289	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PTGS2—prostate cancer	5.75e-05	0.000289	CbGpPWpGaD
Metolazone—CA9—Metabolism—ERCC2—prostate cancer	5.72e-05	0.000288	CbGpPWpGaD
Metolazone—CA4—Metabolism—PIK3CG—prostate cancer	5.59e-05	0.000281	CbGpPWpGaD
Metolazone—CA9—Metabolism—MTHFR—prostate cancer	5.38e-05	0.00027	CbGpPWpGaD
Metolazone—CA12—Metabolism—PIK3CB—prostate cancer	5.37e-05	0.00027	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PTEN—prostate cancer	5.37e-05	0.00027	CbGpPWpGaD
Metolazone—CA12—Metabolism—PTGS2—prostate cancer	5.32e-05	0.000268	CbGpPWpGaD
Metolazone—CA4—Metabolism—INS—prostate cancer	5.29e-05	0.000266	CbGpPWpGaD
Metolazone—CA9—Metabolism—PPARA—prostate cancer	5.28e-05	0.000265	CbGpPWpGaD
Metolazone—CA4—Metabolism—CREBBP—prostate cancer	5.18e-05	0.000261	CbGpPWpGaD
Metolazone—CA5A—Metabolism—EP300—prostate cancer	5.12e-05	0.000257	CbGpPWpGaD
Metolazone—CA7—Metabolism—PTEN—prostate cancer	5.01e-05	0.000252	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PTEN—prostate cancer	5.01e-05	0.000252	CbGpPWpGaD
Metolazone—CA9—Metabolism—CAV1—prostate cancer	4.96e-05	0.000249	CbGpPWpGaD
Metolazone—CA4—Metabolism—PIK3CD—prostate cancer	4.92e-05	0.000247	CbGpPWpGaD
Metolazone—CA5B—Metabolism—EP300—prostate cancer	4.78e-05	0.00024	CbGpPWpGaD
Metolazone—CA7—Metabolism—EP300—prostate cancer	4.78e-05	0.00024	CbGpPWpGaD
Metolazone—CA12—Metabolism—PTEN—prostate cancer	4.64e-05	0.000233	CbGpPWpGaD
Metolazone—CA4—Metabolism—NOS3—prostate cancer	4.64e-05	0.000233	CbGpPWpGaD
Metolazone—CA9—Metabolism—PIK3CG—prostate cancer	4.52e-05	0.000227	CbGpPWpGaD
Metolazone—CA12—Metabolism—EP300—prostate cancer	4.43e-05	0.000223	CbGpPWpGaD
Metolazone—CA4—Metabolism—PIK3CB—prostate cancer	4.28e-05	0.000215	CbGpPWpGaD
Metolazone—CA9—Metabolism—INS—prostate cancer	4.28e-05	0.000215	CbGpPWpGaD
Metolazone—CA4—Metabolism—PTGS2—prostate cancer	4.24e-05	0.000213	CbGpPWpGaD
Metolazone—CA9—Metabolism—CREBBP—prostate cancer	4.19e-05	0.000211	CbGpPWpGaD
Metolazone—CA9—Metabolism—PIK3CD—prostate cancer	3.97e-05	0.0002	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PIK3CA—prostate cancer	3.79e-05	0.00019	CbGpPWpGaD
Metolazone—CA9—Metabolism—NOS3—prostate cancer	3.75e-05	0.000189	CbGpPWpGaD
Metolazone—CA4—Metabolism—PTEN—prostate cancer	3.7e-05	0.000186	CbGpPWpGaD
Metolazone—CA7—Metabolism—PIK3CA—prostate cancer	3.53e-05	0.000178	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PIK3CA—prostate cancer	3.53e-05	0.000178	CbGpPWpGaD
Metolazone—CA4—Metabolism—EP300—prostate cancer	3.53e-05	0.000177	CbGpPWpGaD
Metolazone—CA9—Metabolism—PIK3CB—prostate cancer	3.46e-05	0.000174	CbGpPWpGaD
Metolazone—CA9—Metabolism—PTGS2—prostate cancer	3.43e-05	0.000172	CbGpPWpGaD
Metolazone—CA12—Metabolism—PIK3CA—prostate cancer	3.27e-05	0.000165	CbGpPWpGaD
Metolazone—CA5A—Metabolism—AKT1—prostate cancer	3.09e-05	0.000155	CbGpPWpGaD
Metolazone—CA9—Metabolism—PTEN—prostate cancer	2.99e-05	0.00015	CbGpPWpGaD
Metolazone—CA7—Metabolism—AKT1—prostate cancer	2.89e-05	0.000145	CbGpPWpGaD
Metolazone—CA5B—Metabolism—AKT1—prostate cancer	2.89e-05	0.000145	CbGpPWpGaD
Metolazone—CA9—Metabolism—EP300—prostate cancer	2.85e-05	0.000143	CbGpPWpGaD
Metolazone—CA12—Metabolism—AKT1—prostate cancer	2.68e-05	0.000134	CbGpPWpGaD
Metolazone—CA4—Metabolism—PIK3CA—prostate cancer	2.61e-05	0.000131	CbGpPWpGaD
Metolazone—CA4—Metabolism—AKT1—prostate cancer	2.13e-05	0.000107	CbGpPWpGaD
Metolazone—CA9—Metabolism—PIK3CA—prostate cancer	2.11e-05	0.000106	CbGpPWpGaD
Metolazone—CA9—Metabolism—AKT1—prostate cancer	1.72e-05	8.67e-05	CbGpPWpGaD
